{"id":1775,"date":"2010-07-16T09:40:11","date_gmt":"2010-07-16T13:40:11","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?p=1775"},"modified":"2011-07-19T17:44:55","modified_gmt":"2011-07-19T21:44:55","slug":"fda-reviewing-link-between-arbs-and-cancer","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2010\/07\/16\/fda-reviewing-link-between-arbs-and-cancer\/","title":{"rendered":"FDA reviewing link between ARBs and cancer"},"content":{"rendered":"<p>Last month <a href=\"http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(10)70106-6\/fulltext\">a meta-analysis appearing in the <em>Lancet<\/em><\/a> found\u00a0a modest but statistically significant increase in the risk of cancer associated with the use of angiotensin receptor blockers (ARBs). \u00a0On Thursday <a href=\"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm218845.htm\">the\u00a0FDA issued a safety communication<\/a> and stated that it was\u00a0conducting a review of ARBs. The FDA said that the review was ongoing and that it has not concluded that ARBs increase the risk of cancer, that it believes at this time the benefits of ARBs still outweigh the risks, and that it recommends that ARBs continue to be used as recommended in their approved labels.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FDA issued a safety communication and stated that it was conducting a review of ARBs and cancer.<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,14],"tags":[],"class_list":["post-1775","post","type-post","status-publish","format-standard","hentry","category-general","category-heart-failure"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=1775"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1775\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=1775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=1775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=1775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}